193 related articles for article (PubMed ID: 3716018)
1. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
Brody I
Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
[TBL] [Abstract][Full Text] [Related]
2. Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris.
Brody I
J Invest Dermatol; 1984 May; 82(5):460-4. PubMed ID: 6512269
[TBL] [Abstract][Full Text] [Related]
3. Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris.
Brody I
J Invest Dermatol; 1984 May; 82(5):465-70. PubMed ID: 6512270
[TBL] [Abstract][Full Text] [Related]
4. Low strength anthralin in psoriasis.
Montes LF; Wilborn WH; Brody I
J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
6. A topical treatment program for psoriasis with low anthralin concentrations.
Brody I; Johansson A
J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
[TBL] [Abstract][Full Text] [Related]
7. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H
Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
[No Abstract] [Full Text] [Related]
8. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
[TBL] [Abstract][Full Text] [Related]
9. Detection of anthralin in skin during treatment.
Juhlin L; Schroot B
Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
Brody I
Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
[No Abstract] [Full Text] [Related]
11. Ultrastructural changes in psoriatic epidermis following anthralin treatment.
Wilborn WH; Montes LF
J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841
[No Abstract] [Full Text] [Related]
12. The influence of treatment of the paralesional skin with dithranol on healing in psoriasis.
Stankler L; Dave VK
Br J Dermatol; 1975 Jan; 92(1):57-61. PubMed ID: 1098687
[TBL] [Abstract][Full Text] [Related]
13. Measurement of the response of psoriasis to short-term application of anthralin.
Marsden JR; Coburn PR; Marks J; Shuster S
Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098
[TBL] [Abstract][Full Text] [Related]
14. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
Schauder S; Mahrle G
Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
[TBL] [Abstract][Full Text] [Related]
15. Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study.
Murphy GF; Austen KF; Fonferko E; Sheffer AL
J Allergy Clin Immunol; 1987 Oct; 80(4):603-11. PubMed ID: 3668125
[TBL] [Abstract][Full Text] [Related]
16. Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules.
Röhlich P; Anderson P; Uvnäs B
J Cell Biol; 1971 Nov; 51(21):465-83. PubMed ID: 4107023
[TBL] [Abstract][Full Text] [Related]
17. [Topical treatment of psoriasis].
Suhonen R
Duodecim; 1985; 101(11):1135-41. PubMed ID: 4017905
[No Abstract] [Full Text] [Related]
18. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
Kanerva L
Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
